Background Image
Table of Contents Table of Contents
Previous Page  44 / 76 Next Page
Information
Show Menu
Previous Page 44 / 76 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 28, No 1, January/February 2017

42

AFRICA

levels. The plain sterile tubes for blood and sterile urine cups for

saliva contained 500 kIU aprotonin to preclude proteolysis, and

after clotting, the samples, were immediately centrifuged at 4 000

rpm and kept frozen (−80°C) pending analysis.

All samples were subjected to conventional laboratory analyses

using an autoanalyser, including determination of glucose, total

cholesterol (TC), triglyceride (TG), low-density lipoprotein

cholesterol (LDL-C) and high-density lipoprotein cholesterol

(HDL-C) concentrations. Serum troponin I concentration was

measured by chemiluminescence using a Siemens IMMULITE

2000 XPi immunoassay system (Siemens Healthcare Diagnostics

Inc, Flanders NJ, USA) and commercial kits (Siemens Healthcare

Diagnostics Products Ltd, Llanberis, United Kingdom).

Serum and saliva adropin levels were measured using the

same commercial EIA kits (cat no: EK-032-35) and procedures

(Phoenix Pharmaceuticals, Belmont, CA, USA). The saliva

adropin assay was validated according to previously published

methods.

25

The lowest detectable concentration of adropin was

0.01 ng/ml, with intra- and inter-assay variations of 10 and 15%,

respectively. Absorbance at 450 nm was measured with an ELX

800 ELISA reader.

Salivary glands were obtained from the Department of

Pathology. They had been removed by surgeons only because

of calcification. Adropin was screened immunohistochemically

using the Hsu

et al

. avidin–biotin peroxidase complex (ABC)

method, as recently described.

26

Adropin primary antibody was

diluted 1/200 (rabbit polyclonal anti-adropin antibody, ab12800;

Abcam, Cambridge, UK), applied and incubated for 60 min in a

humid chamber at room temperature.

Immunostained sections from the parotid, submandibular

and sublingual glands were examined with an Olympus BX 50

photomicroscope. Immunohistochemical staining was scored for

both intensity and prevalence on a scale of 0 to

+

3 (0: absent,

+

1:

weak,

+

2: medium,

+

3: strong).

Statistical analysis

All statistical analyses were performed using SPSS for Windows

version 21.0 (SPSS Inc, Chicago, USA). Differences between groups

were analysed with the Kruskal–Wallis test. The Mann–Whitney

U

-test was used to compare parameters within groups. Comparisons

of mean values between groups were expressed as

±

2 SEM.

Fig. 1.

Adropin immunohistochemistry of the intercalated duct of the parotid, striated and interlobular ducts of the submandibular,

and mucous acinus of the sublingual glands. A1, parotid negative; A2: parotid adropin immunoreactivity; B1, sublingual nega-

tive; B2: sublingual adropin immunoreactivity, C1, submandibular negative; C2, submandibular adropin immunoreactivity. Red

colour shows adropin immunoreactivity. Magnification

×

400.